JBM (Healthcare) Limited (HKG:2161)

Revenue by Product

Financials in millions HKD. Fiscal year is April - March.

Year Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Proprietary Chinese Medicines	405.45M
Proprietary Chinese Medicines Growth	5.01%
Branded Medicines	272.23M
Branded Medicines Growth	43.20%
Health and Wellness Products	104.61M
Health and Wellness Products Growth	44.92%

Revenue by Geography

Financials in millions HKD. Fiscal year is April - March.

Year Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Hong Kong	562.01M
Hong Kong Growth	21.43%
China	146.98M
China Growth	14.45%
Macau	38.64M
Macau Growth	49.49%
Singapore	15.56M
Singapore Growth	24.43%
Other	19.10M
Other Growth	1.58%